A Case of Hypoglycaemic Symptoms in Non-Hypoglycaemic Patient Whose Symptoms Improved on Oral Octreotide: A Case Report (ENDO 2026) - Jun 2, 2026 - Abstract #SAT-870; Pres time: Jun 13, 2026; 09:30 AM - 04:30 PM; Location: ENDOExpo; Poster Floor; "Intervention and Outcome: A trial of 20 mg oral octreotide (Mycapssa) once daily along with continuous glucose monitoring provided notable improvement demonstrated by increase in inter-meal duration, decrease in episodes of sudden hypoglycaemia and reduction in subjective hypoglycaemic symptoms...Furthermore, this case highlights the importance of focusing on diagnostic gap and treatment instead of misattribution of the patient's symptoms to psychological factors. Key words- Hyperglycemia, Octreotide, hyperinsulinemia, hypoglycemia, MEN"
Case report • Clinical • CNS Disorders • Diabetes • Endocrine Disorders • Hypoglycemia • Immunology • Migraine • Polyendocrine Metabolic Ovarian Syndrome • Solid Tumor • IGF1
|
|
Muhammad Asad Shabbir, MBBS, MD; Jyoti Pun Mehta, RN
|